[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100628272":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":33,"locations":42,"responsibleParty":58,"collaborators":11,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":70,"maxAge":11,"enrollmentInfo":71,"targetDuration":11,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":45,"whyStopped":11,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"biofeedback and standard of care with tilt table testing","EXPERIMENTAL",null,[13],"Diagnostic Test: biofeedback and standard of care with tilt table testing",{"label":15,"type":16,"description":11,"interventionNames":17},"biofeedback and standard of care without tilt table testing","ACTIVE_COMPARATOR",[18],"Diagnostic Test: no tilt table testing",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":11},"DIAGNOSTIC_TEST","tilt table testing",[9],{"type":21,"name":25,"description":26,"armGroupLabels":27,"otherNames":11},"no tilt table testing","only biofeedback, no tilt table testing",[15],[29],{"name":30,"affiliation":31,"role":32},"Frederik J de Lange, MD, PhD","AmsterdamUMC","PRINCIPAL_INVESTIGATOR",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":11,"email":38},"Thomas T Boel, MD","CONTACT","31 20 5669111","t.t.boel@amsterdamumc.nl",{"name":40,"role":36,"phone":11,"phoneExt":11,"email":41},"Elvira S Amaral Gomes","e.s.amaralgomes@amsterdamumc.nl",[43],{"facility":44,"status":45,"city":46,"state":11,"zip":11,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Amsterdam UMC","RECRUITING","Amsterdam","Netherlands","NL",{"type":50,"coordinates":51},"Point",[52,53],4.88969,52.37403,{"lat":53,"lon":52},[56],{"name":57,"role":36,"phone":37,"phoneExt":11,"email":38},"Thomas T Boel",{"type":32,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Frederik de Lange","Doctor","100628272","assesment-of-the-clinical-benefit-of-provocation-on-tilt-table-in-syncope-patients-tiltsync-trial-100628272",false,"NCT07459478","Assesment of the Clinical Benefit of Provocation on Tilt-table in SYNCope Patients, TiltSYNC-trial","Multicenter RCT to Assess the Clinical Benefit of Provocation on Tilt-table in SYNCope Patients, TiltSYNC-trial","TiltSYNC","Inclusion Criteria:\n\n* All patients \\>18 years of age with certain\u002Fhighly likely vasovagal syncope after the guideline based syncope evaluation\n\nExclusion Criteria:\n\n* Those aged \\\u003C18 years\n* Any patient diagnosed with another form of reflex syncope other than vasovagal syn-cope\n* Contraindication for tilt table testing at the discretion of the responsible physician\n* Those with a learning disability\n* Those presenting with pre-syncope and not with complete loss of consciousness\n* Those who are unwilling to provide informed consent\n* Those already diagnosed prior to evaluation who are referred for specific treatment op-tions","ALL","18 Years",{"count":72,"type":73},238,"ESTIMATED","INTERVENTIONAL",[76],"NA","multicenter prospective randomized controlled comparison of biofeedback with tilt table testing (investigational management strategy) vs biofeedback without tilt table testing (reference management strategy) in patients with certain\u002Fhighly likely vasovagal syncope",[79],"Vasovagal Syncope (VVS)",[81,82,83,84,85],"Suspected vasovagal syncope","Tilt table testing","Syncope","Therapeutic","Biofeedback","2026-03-09",{"date":88,"type":89},"2026-03-11","ACTUAL",{"date":91,"type":89},"2025-10-30",{"date":93,"type":73},"2028-03-01",{"name":5,"class":6},1]